Sign in

NCT06745895Recruiting

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening (MATCHES)

Source: ClinicalTrials.gov · Last updated 16 Sept 2026

Brief summary (registry, in English)

This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC screening among FQHC patients ages 45-75.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
350 (estimated)
First submitted
17 Dec 2024
Start date
21 Oct 2024
Primary completion date
31 Oct 2027
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
NCT number
NCT06745895

What you commit to

  • Study type: Interventional
  • Planned participants: 350
  • From 21 Oct 2024 to the primary completion date, 31 Oct 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Participants that do not meet all Inclusion Eligibility requirements will be excluded.

Who the study is looking for

  • Participants must be receiving care at one of the participating FQHC clinics.
  • Participants must be 45-75 years of age.
  • Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months.
  • Participants must never have had Hepatitis C Virus (HCV) antibody screening.
  • Participants must be able to read, write, and understand English or Spanish.
  • Participants must have no personal history of CRC or current presumptive CRC symptoms such as unresolved rectal bleeding or abdominal pain/bloating.
  • Participants must be at average risk for CRC (no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC).
  • Participants must be asymptomatic for HCV.
  • Participants receiving intervention materials must be able and willing to complete surveys and receive the patient level intervention.
  • Participants completing qualitative interviews must be willing to complete a remote interview via phone or teleconference software such as ZOOM.
  • Participants completing qualitative interviews must be willing to be audio recorded.
  • Participants recruited for qualitative interviews only (did not receive MATCHES intervention materials) must have a clinic visit within prior two months.
  • All Participants must be able to provide informed consent.

Age in the registry: 45 years to 75 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Moffitt Cancer Center
Coordinator of this site? Confirm its status
TampaUnited StatesRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.